[HTML][HTML] MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer
X Zhao, J Li, S Huang, X Wan, H Luo… - American journal of …, 2015 - ncbi.nlm.nih.gov
Background: MicroRNAs are a class of endogenous single strand non-coding RNAs that are
involved in many important physiological and pathological processes. The purpose of this …
involved in many important physiological and pathological processes. The purpose of this …
[HTML][HTML] Tumor protein D52 (TPD52) inhibits growth and metastasis in renal cell carcinoma cells through the PI3K/Akt signaling pathway
Z Zhao, H Liu, J Hou, T Li, X Du, X Zhao, W Xu… - Oncology …, 2017 - ncbi.nlm.nih.gov
Abstract Tumor protein D52 (TPD52) is a member of the TPD52-like protein family and plays
different roles in various types of malignancies. However, its role in renal cell carcinoma …
different roles in various types of malignancies. However, its role in renal cell carcinoma …
Tumor protein D52 (isoform 3) contributes to prostate cancer cell growth via targeting nuclear factor-κB transactivation in LNCaP cells
C Dasari, DP Yaghnam, R Walther… - Tumor …, 2017 - journals.sagepub.com
Our previous study showed that TPD52 overexpression could increase migration and
proliferation of LNCaP cells contributing to the development of prostate cancer. However …
proliferation of LNCaP cells contributing to the development of prostate cancer. However …
miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma
H Zhao, L Feng, R Cheng, M Wu, X Bai, L Fan, Y Liu - Cellular Signalling, 2024 - Elsevier
Abstract Ovarian Carcinoma (OvCa) is characterized by rapid and sustained growth,
activated invasion and metastasis. Studies have shown that microRNAs recruit and alter the …
activated invasion and metastasis. Studies have shown that microRNAs recruit and alter the …
[HTML][HTML] The PVT1/miR-612/CENP-H/CDK1 axis promotes malignant progression of advanced endometrial cancer
R Cong, F Kong, J Ma, Q Li, H Yang… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Our previous study introduced the oncogenic role of the long non-coding RNA
plasmacytoma variant translocation 1 (PVT1) in endometrial cancer (EC). In this study, we …
plasmacytoma variant translocation 1 (PVT1) in endometrial cancer (EC). In this study, we …
KRT7 promotes epithelial-mesenchymal transition in ovarian cancer via the TGF-β/Smad2/3 signaling pathway
Q An, T Liu, MY Wang, YJ Yang… - Oncology …, 2021 - spandidos-publications.com
Keratin 7 (KRT7) is a member of the keratin gene family. KRT7 is abnormally expressed in
various types of cancer and promotes the malignant progression of tumors. However, the …
various types of cancer and promotes the malignant progression of tumors. However, the …
Identification of PDZD11 as a Potential Biomarker Associated with Immune Infiltration for Diagnosis and Prognosis in Epithelial Ovarian Cancer
X Chen, Z Li, Y Feng, Z Yang, B Zhao - International Journal of …, 2024 - Taylor & Francis
Purpose Evidence has indicated that PDZD11 is involved in regulating adherens junction.
However, the distinct effect of its aberrant expression on epithelial ovarian cancer (EOC) …
However, the distinct effect of its aberrant expression on epithelial ovarian cancer (EOC) …
MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B …
H Zhang, K Zhang, Z Xu, Z Chen, Q Wang, C Wang… - BMC cancer, 2021 - Springer
Background Ovarian cancer (OC) is a life-threatening gynecological malignancy where
dysregulation of microRNAs (miRNAs) is frequently implicated. This study focuses on the …
dysregulation of microRNAs (miRNAs) is frequently implicated. This study focuses on the …
[HTML][HTML] Tumor protein D52 promotes breast cancer proliferation and migration via the long non-coding RNA NEAT1/microRNA-218-5p axis
J Ren, Y Chen, W Kong, Y Li, F Lu - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Background Breast cancer is an aggressive disease with high morbidity and mortality rates
among women globally. Tumor protein D52 (TPD52) is an oncogene in breast cancer; …
among women globally. Tumor protein D52 (TPD52) is an oncogene in breast cancer; …
Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value
S Hong, N Fu, S Sang, X Ma, F Sun… - Journal of Ovarian …, 2024 - Springer
Background Ovarian cancer (OC) is a severe gynecological malignancy with significant
diagnostic and therapeutic challenges. The discovery of reliable cancer biomarkers can be …
diagnostic and therapeutic challenges. The discovery of reliable cancer biomarkers can be …